ArticleDiscover oncology2025
Radiation-induced acute pericarditis after palliative spine radiation in a non-small cell lung cancer patient on osimertinib: a case report.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation-induced acute pericarditis is a rare but life-threatening condition requiring prompt recognition. We report a case of acute pericarditis occurring immediately after palliative spine radiation in a 54-year-old male with non-small cell lung cancer (NSCLC) on Osimertinib. He initially presented with brain, liver, spleen, and bone metastases and was treated with erlotinib and whole-brain radiation. Disease progression prompted a switch to Osimertinib and palliative spine radiation for spinal cord compression. Two days post-radiotherapy, he developed acute chest pain, diagnosed as radiation-induced pericarditis, possibly exacerbated by Osimertinib. Symptoms improved with aspirin and colchicine, and Osimertinib was safely resumed. This case highlights the importance of early recognition of radiation-induced pericarditis, particularly in patients receiving concurrent thoracic radiation and Osimertinib, to ensure timely management and prevent complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.